CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2

This adverse event was reported 9 times

CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2 is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOMETASONE FUROATE MONOHYDRATE 1 0.0020
1 BENDAMUSTINE HCL 4 0.0003
2 FLUDARABINE PHOSPHATE 5 0.0001
3 CLADRIBINE 1 0.0001
4 DIPHENHYDRAMINE HCL 1 0.0001
5 VALGANCICLOVIR 1 0.0001
6 ALEMTUZUMAB 1 0.0001
7 FEXOFENADINE HYDROCHLORIDE 1 0.0000
8 MELPHALAN HYDROCHLORIDE 1 0.0000
9 FILGRASTIM 1 0.0000
See all drugs enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2